News
麻豆社 CBD research collaboration helping develop new therapies for treating chronic pain
Published: 10 February 2021
Important pain research from the is helping develop cannabidiol (CBD) therapies to treat chronic pain.
US company has teamed up with聽the 麻豆社 Research Centre for Cannabis to fund a聽pre-clinical study to determine if their plant-based CBD Aloe Vera product can help people suffering from interstitial cystitis, a chronic bladder condition. Evidence suggests CBD is beneficial for treating a wide range of clinical conditions and could be an effective alternative to opioid treatments. This study is an example of how knowledge from our laboratories benefits the community at large.聽
To learn more, check out these articles:
Photo (above): The Sharif Lab members at 麻豆社 Pain Day, January 23, 2020